Amarin Corp Plc (AMRN)

[sstyles]

As a follow up to a post from oneragman on AdCom members. I am starting to research them.
Roster: https://www.fda.gov/advisory-committees/endocrinologic-and-metabolic-drugs-advisory-committee/endocrinologic-and-metabolic-drugs-advisory-committee-roster

As has been reported Dr. Michael Blaha has been quoted with positive comments on REDUCE-IT.
See: https://www.nbcnews.com/health/heart-health/drug-fish-oil-cuts-risk-heart-attack-stroke-study-finds-n934701

I thought it is also interesting that Elizabeth Chrischilles has done research looking at ways to reduce cardiovascular disease and suggests she is open to new approaches.
See: https://ahajournals.org/doi/10.1161/CIRCOUTCOMES.117.004188

Also from https://icts.uiowa.edu/about-us/leadership/elizabeth-chrischilles-phd (scroll down and look at publications):

4 R01 HL116311 (Carter, Barry)
08/08/13-07/31/18
NIH
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care (ICARE) Trial
Objective: To conduct a multi-center, cluster-randomized study utilizing a centralized Prevention Health & Cardiovascular Risk Service to support the efforts of rural medical offices to improve adherence to the Guideline Advantage metrics for reducing cardiovascular risk.
Role: Co-Investigator

R18 HL116259 (Carter, Barry)
04/01/14-03/31/19
NIH
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention: MED-FOCUS
Objective: To conduct a multi-center, cluster-randomized study utilizing a centralized Cardiovascular Risk Service for medical offices with large geographic, racial and ethnic diversity to improve cardiovascular disease guideline adherence using the Guideline Advantage metrics.
Role: Co-Investigator

CDRN-1501-26643 (Chrischilles, Elizabeth)
09/07/15-09/07/18
Subcontract with University of Kansas Medical Center Research Institute, Inc/Patient-Centered Outcomes Research Institute
Greater Plains Collaborative Clinical Data Research Network – PCORnet Phase II
The goal of the CDRN is to create a national data infrastructure for practice-based comparative effectiveness research. The initiative enhances the clinical decision making around empirical evidence of effectiveness and patient preferences. The initiative emphasizes engaging patients, practicing clinicians, healthcare IT programs and health system leaders in the design and implementation of comparative effectiveness studies.

5R21 HS023952-01 (Chrischilles, Elizabeth)
04/01/15-03/31/18
AHRQ
Design and Testing of a Mobile Cardiovascular Risk Service with Patient Partners
Risk factors for cardiovascular disease are poorly controlled even for patients who frequently visit their physician, leading to large numbers of preventable cardiovascular events such as heart attacks and strokes.
Research from integrated healthcare systems suggests that risk factors can be controlled better and treatment strategies for cardiovascular disease can be markedly improved by using a centralized cardiovascular risk service (CVRS) managed by pharmacists. The objective of this project is to develop and test a mobile app enabled, pharmacist managed CVRS for disseminating and implementing evidence-based guidelines in practice.